Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Mar-Apr;63(2):125-133.
doi: 10.1016/j.pcad.2020.02.003. Epub 2020 Feb 5.

Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV

Affiliations
Randomized Controlled Trial

Protocol paper: Stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV

Stephen K Williams et al. Prog Cardiovasc Dis. 2020 Mar-Apr.

Abstract

People living with HIV (PWH) are at higher risk for cardiovascular disease (CVD) and stroke in comparison to their non-infected counterparts. The ABCS (aspirin-blood pressure control-cholesterol control-smoking cessation) reduce atherosclerotic (ASCVD) risk in the general population, but little is known regarding strategies for promoting the ABCS among PWH. Guided by the Consolidated Framework for Implementation Research (CFIR), we designed multilevel implementation strategies that target PWH and their clinicians to promote appropriate use of the ABCS based on a 10-year estimated ASCVD risk. Implementation strategies include patient coaching, automated texting, peer phone support, academic detailing and audit and feedback for the patient's clinician. We are evaluating implementation through a stepped wedge cluster randomized trial based on the Reach-Effectiveness-Adoption-Maintenance/Qualitative-Evaluation-for-Systematic-Translation (RE-AIM/QuEST) mixed methods framework that integrates quantitative and qualitative assessments. The primary outcome is change in ASCVD risk. Findings will have important implications regarding strategies for reducing ASCVD risk among PWH.

Keywords: Cardiovascular disease; HIV; Implementation effectiveness; Primary prevention; Risk factors.

PubMed Disclaimer

Conflict of interest statement

Statement of conflict of interest

None of the authors have any conflicts of interests with regard to this publication.

Figures

Fig. 1.
Fig. 1.
Implementation using the CFIR.
Fig. 2.
Fig. 2.
Patient subject study flow.
Fig. 3.
Fig. 3.
Project timeline.

References

    1. Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration. Lancet 2014;384 (9939):241–248. - PubMed
    1. Feinstein MJ, Hsue PY, Benjamin LA, et al. Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association. Circulation 2019;140(2):e98–e124. - PMC - PubMed
    1. Baker JV, Duprez D. Biomarkers and HIV-associated cardiovascular disease. Curr Opin HIV AIDS 2010;5(6):511–516. - PMC - PubMed
    1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2019;73(24):e285–e350. - PubMed
    1. Arnett Donna K, Blumenthal Roger S, Albert Michelle A, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation 2019;0(140): e596–e646. - PMC - PubMed

Publication types

MeSH terms